行情

NBY

NBY

Novabay制药
AMEX

实时行情|Nasdaq Last Sale

0.1999
-0.0001
-0.05%
交易中 14:59 05/24 EDT
开盘
0.1985
昨收
0.2000
最高
0.2069
最低
0.1880
成交量
12.65万
成交额
1.68万
52周最高
0.8772
52周最低
0.1711
市值
1,051.84万
市盈率(TTM)
-1.3265
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解NBY最新的财务预测,通过NBY每股收益,每股净资产,每股现金流等数据分析Novabay制药近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

50.00%强力推荐
50.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测NBY价格均价为3.100,最高价位4.000,最低价为2.200。
最高4.000
均价3.100
最低2.200
现价0.1999
EPS
实际EPS
预期EPS
-0.04-0.03-0.02-0.01
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
机构持股
总机构数: 20
机构持股: 64.76万
持股比例: 1.23%
总股本: 5,261.84万
类型机构数股数
增持
3
38.36万
建仓
7
17.45万
减持
6
9.77万
平仓
2
1.24万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-2.52%
制药与医学研究
-0.01%
高管信息
Non-Executive Chairman/Independent Director
Paul Freiman
Chief Executive Officer/Chief Compliance Officer/General Counsel/Director/IR Contact Officer
Justin Hall
Chief Financial Officer/Treasurer
Andrew Jones
Other/Director
Audrey Kunin
Director
Mijia Wu
Director
Yongxiang Zheng
Independent Director
Julie Garlikov
Independent Director
Swan Sit
Independent Director
Yenyou Zheng
暂无数据
暂无数据
NBY 简况
NovaBay Pharmaceuticals, Inc. is a medical device company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is a solution of hypochlorous acid that acts as an antimicrobial preservative in solution and has been shown to neutralize bacterial toxins in laboratory tests. It develops additional products containing its hypochlorous acid, including NeutroPhase and PhaseOne for the wound care market. The Company's dermatology product includes CelleRx Clinical Reset, which is a facial spray that disrupts the layer of bacteria that settles and grows on the face. Its wound care business includes the business of NeutroPhase and PhaseOne product, which are used for the cleansing and irrigation of intraoperative pocket lavage, stasis ulcers, leg ulcers, diabetic foot ulcers, minor burns, superficial abrasions, wounds and moistening absorbent wound dressings.

微牛提供NovaBay Pharmaceuticals, Inc.(AMEX-NBY)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NBY股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NBY股票基本功能。